Friday, 16 June 2017 641 on upper extremities. None of patients had allodynia, but impaired vibratory sensibility was found in all patients with NP. Clinical signs of radiculopathy were present in 6 patients. Hypoesthesia was registered in typical dermatomes in 6/11 (54.5%) of patients, with asymmetric hyporeflexia in 2/11 (18.1%) patients on lower, and none of patients on upper extremities. Despite the fact that almost every patient had symptoms and signs suggesting polyneuropathy, in only four of them demyelinating polyneuropathy was detected by ENG. Background: Systemic sclerosis (SSc) is an uncommon autoimmune multisystem disease associated with reduced life expectancy compared with the general population.
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Taking all into account, these data support an increased vigilance for infections, as well as the need to implement effective measures to control modifiable cardiovascular risk factors, including screening for PAH.
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Although microvascular and macrovascular abnormalities frequently coexist in disease such as diabetes mellitus and other vascular diseases, the possible association between microvascular failure and macrovasculopathy in SSc patients has not been deeply investigated (1). Objectives: The aim of the study was to estimate in SSc patients the macrovascular function by measuring of the Intima-Media Thickness (IMT) of high-caliber and periferic small-caliber arteries, and to evaluate the possible correlation with microvascular blood perfusion (BP) assessed by Laser Speckle Contrast Analysis (LASCA). Methods: Twenty-nine female SSc patients (mean age 65.7±12.07 SD years, mean disease duration 97.3±68.01 SD months) were enrolled after informed consent. Carotid IMT was evaluated through B-mode US imaging (Esaote, Genoa) using transducer 18 MHz on both right and left common carotid arteries (CCA) as well as ulnar (UA) and radial arteries (RadA). Therefore, an average IMT score was obtained for any evaluated site. Peripheral BP was assessed by LASCA (Perimed-Sweden) at the level of fingertips, periungueal areas, dorsum and palm of both hands, and face. The BP values were reported as perfusion units (PU) (2). In addition nailfold videocapillaroscopy (NVC) in order to assess the microvascular morphological status was done by nailfold video capillaroscopy (NVC) considering the different progressive SSc patterns and the microangiopathy evolution score (MES) (3-4). Results: A positive correlation was observed between CCA IMT and age (p=0.004) and disease duration (p=0.02). On the other hand, no significant correlations were observed between IMT of periferic small-caliber arteries (UA and RadA) and age or disease duration. Positive correlations were found between microvascular damage, as assessed by MES and IMT at the level of periferic smallcaliber arteries.No significant correlation was observed between macrovascular involvement of high-caliber arteries and peripheral BP as assessed by LASCA. However, at the peripheral site a correlation was observed between RadA IMT and palm (p=0.05), periungueal (p=0.04) and dorsum of hand BP (p=0.0006), as assessed by LASCA. UA IMT showed a correlation limited to the dorsum of the hand (p=0.003). Conclusions: Significant correlations seem to exist between increased IMT of periferic small-caliber arteries (macrocirculation) and altered peripheral BP (LASCA) at the level of hand microvessels (microcirculation) in SSc patients. These results were found strength by a further correlation with the microvascular damage (MES). Background: Anti-melanoma differentiation-associated gene 5 (MDA5) antibody in clinically amyopathic dermatomyositis (CADM) is associated with rapidly progressive interstitial lung disease (RPILD). RPILD is a rare disorder with a bad outcome, and therefore the intensive treatment with combinational immunosuppressive drugs in addition to steroid need to be initiated. However until now, good serological markers to evaluate disease activity in CADM have not been established. Activated alveolar macrophage is one of the possible candidates worsening the condition of RPILD. Objectives: To investigate new serological markers of disease activity in anti-MDA5 antibody positive CADM for therapeutic indication. Methods: Thirteen anti-MDA5 antibody positive CADM patients were enrolled. We serially measured serum anti-MDA5 antibody, and neopterin and IL-18 as markers of activated macrophage by serum enzyme-linked immunosorbent assay. We tracked them at three points in each patients: before treatment, soon after a series of intravenous cyclophosphamide pulse therapy (about 3months later after onset) and the remission status (about one year later after onset). Results: Four patients died soon after the initial treatment because of the deterioration of RPILD. At onset of the disease, the levels of serum anti-MDA5 antibody and neopterin were extremely high (169.75±24.3 index and 27.6±24.1 nmol/l) in all patients. However serum IL-18 level was almost normal (479.3±301.4 pg/ml). Among the 9 surviving patients, it took about one year for anti-MDA5 antibody level to decrease to the normal range. On the other hand, neopterin level decreased quickly after the initial treatment. The level of anti-MDA5 antibody transitioned from 169.75±24.3 index to 93.1±50.1 index, and then to 44.8±45.4 index (P=0.003). Neopterin level transitioned from 27.6±24.1 nmol/l to 9.1±6.5 nmol/l, and then to 6.4±5.0 nmol/l (P=0.006). IL-18 level transitioned from 479.3±301.4 pg/ml to 246.0±175.8 pg/ml, and then to 233.3±180.1 pg/ml (P=0.02). The level of anti-MDA5 didn't correlate with the level of ferritin (r=0.28), neopterin (r=0.16), IL-18 (r=0.06) and soluble IL-2 receptor (r=0.27), but the level
